Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis

(2018) Brad H. Rovin et al.   KIDNEY INTERNATIONAL

Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art

(2017) Chi Chiu Mok   Expert Review of Clinical Immunology

Multitarget Therapy for Maintenance Treatment of Lupus Nephritis

(2017) Haitao Zhang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Disease-specific quality of life in patients with lupus nephritis

(2017) M Jolly et al.   LUPUS

Tacrolimus use in lupus nephritis: A systematic review and meta-analysis

(2016) Jennifer Hannah et al.   AUTOIMMUNITY REVIEWS

Towards new avenues in the management of lupus glomerulonephritis

(2016) C. C. Mok   Nature Reviews Rheumatology

Multitarget Therapy for Induction Treatment of Lupus Nephritis

(2015) Zhihong Liu et al.   ANNALS OF INTERNAL MEDICINE

Mycophenolate mofetil for lupus nephritis: an update

(2015) Chi Chiu Mok   Expert Review of Clinical Immunology

Tacrolimus for the prevention and treatment of rejection of solid organ transplants

(2015) Joseph R. Scalea et al.   Expert Review of Clinical Immunology

Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis

(2015) Ruyi Liao et al.   PLoS One

Predictors of Long-Term Renal Outcome in Lupus Nephritis Trials: Lessons Learned from the Euro-Lupus Nephritis Cohort

(2015) Maria Dall'Era et al.   Arthritis & Rheumatology

Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up

(2014) Chi Chiu Mok et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of Renal Disease on the Standardized Mortality Ratio and Life Expectancy of Patients With Systemic Lupus Erythematosus

(2013) C. C. Mok et al.   ARTHRITIS AND RHEUMATISM

Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study

(2013) CC Mok et al.   LUPUS

Overview of lupus nephritis management guidelines and perspective from Asia

(2013) Chi Chiu Mok et al.   NEPHROLOGY

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

(2012) George K Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

Abatacept for lupus nephritis: Alternative definitions of complete response support conflicting conclusions

(2012) David Wofsy et al.   ARTHRITIS AND RHEUMATISM

Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE

(2012) MA Dooley et al.   LUPUS

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

(2012) Bevra H. Hahn et al.   ARTHRITIS CARE & RESEARCH

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

(2011) Richard Furie et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis

(2011) X. Li et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

(2011) Mary Anne Dooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial

(2010) Wei Chen et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Role of Antimicrobial Selective Pressure and Secondary Factors on Antimicrobial Resistance Prevalence inEscherichia colifrom Food-Producing Animals in Japan

(2010) Kazuki Harada et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study

(2010) J. Zavada et al.   LUPUS

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy

(2009) H. A. Austin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

(2008) Christian Faul et al.   NATURE MEDICINE